Last reviewed · How we verify
TRS003
At a glance
| Generic name | TRS003 |
|---|---|
| Sponsor | Zhejiang Teruisi Pharmaceutical Inc. |
| Modality | Biologic |
| Phase | Phase 3 |
Approved indications
Common side effects
Key clinical trials
- A Study Assessing the Interchangeability Between TRS003 and Bevacizumab® For CRC (PHASE3)
- A Study to Compare the Similarity in Efficacy and Safety Between TRS003 and China-approved Bevacizumab® in NSCLC (PHASE3)
- A Study to Compare Pharmacokinetic and Safety of TRS003 to China-approved Bevacizumab and US-licensed Avastin® (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |